Register for a free Asia-Pacific Spinal Implant and Vertebral Compression Fracture Market brochure or synopsis

Scientists have developed a simple, low-cost spinal fusion device to reduce chronic back pain that may help avoid the need for more invasive surgery and painful bone grafts. Researchers in Melbourne, Australia anticipate the innovative medical device, Thru-Fuze, will transform spinal fusion surgery, which is used when conservative therapies such as physical therapy, medication and injections have failed.

The human trials are expected to begin in Australia later this year, the researchers said. Spinal fusion stabilises the spine to prevent the extraneous movement that causes back pain. Chronic back pain from spinal disorders or degenerative disc disease is a major public health issue around the world and is the most common reason for pain and disability in people aged under 50. Bill Walsh, Director of Surgical and Orthopaedic Laboratories at University of New South Wales in Australia, said the device will allow faster, simpler surgery with minimal radiation exposure compared to current methods.

“Existing methods of spinal fusion use rod or cage systems that require screws to be drilled into the spine and a painful bone graft harvested, which is the material used to form the bridge and obtain the fusion between the vertebrae in the spine,” Walsh said. “These systems are very costly, difficult and time consuming to implant and they also have relatively variable rates of fusion success,” he said. “Existing methods rely on the bone to make its way right across the vertebrae and it can take up to a year to find out if the surgery has been a success.”

Non-union, or failure to achieve a solid fusion, has been reported in over 50 per cent of patients using existing methods of spinal fusion. The new device stabilises the spine without the need for a bone graft. Pre-clinical and laboratory testing in animal models has shown fusion of bone on and through the device after it is placed between vertebrae, resulting in rapid ‘biomechanical’ fixation.

“Over time, the device then acts as a bridge between the adjacent vertebrae for additional bone to grow across, fusing the adjacent vertebrae together, bone to bone,” Walsh said.

For Further Information
More on the Australian spine device market can be found in the report published by iData entitled Asia-Pacific Spinal Implant and Vertebral Compression Fracture Market. This report covers China, Taiwan, Japan, South Korea and Australia, and includes the following market segments: Spinal Fusion, Thoracolumbar Fixation, Cervical Artificial Discs, Interbody Fusion, Artificial Discs, Dynamic Stabilization, and the Vertebral Compression Fracture Market.

The global series on the spinal implant and VCF markets covers the U.S., Australia, Japan, South Korea, China, Taiwan, and 15 countries in Europe. Full reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. Register online or email us at [email protected] for a Asia-Pacific Spinal Implant and Vertebral Compression Fracture Market report brochure and synopsis.

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.

Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook:
Follow us on LinkedIn:
Follow us on Twitter: